Healthcare provider profile · identity verified

Glen E Anderson, PA-C

Physician Assistant · GANSEVOORT, NY · NPI 1801061288

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	273	86
Amlodipine Besylate	Amlodipine Besylate	254	74
Lisinopril	Lisinopril	250	76
Omeprazole	Omeprazole	235	83
Levothyroxine Sodium	Levothyroxine Sodium	208	65
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	161	46
Metoprolol Succinate	Metoprolol Succinate	135	47
Metformin Hcl	Metformin Hcl	130	39
Gabapentin	Gabapentin	122	40
Losartan Potassium	Losartan Potassium	111	35
Hydrochlorothiazide	Hydrochlorothiazide	103	32
Albuterol Sulfate Hfa	Albuterol Sulfate	101	49
Eliquis	Apixaban	99	20
Famotidine	Famotidine	96	22
Alprazolam	Alprazolam	92	28
Pantoprazole Sodium	Pantoprazole Sodium	90	26
Duloxetine Hcl	Duloxetine Hcl	80	17
Jardiance	Empagliflozin	80	17
Prednisone	Prednisone	74	56
Metoprolol Tartrate	Metoprolol Tartrate	72	21
Pravastatin Sodium	Pravastatin Sodium	71	21
Simvastatin	Simvastatin	70	28
Sertraline Hcl	Sertraline Hcl	68	20
Tizanidine Hcl	Tizanidine Hcl	68	21
Rosuvastatin Calcium	Rosuvastatin Calcium	67	27
Potassium Chloride	Potassium Chloride	65	22
Topiramate	Topiramate	64	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	63	20
Furosemide	Furosemide	61	26
Ozempic	Semaglutide	59	18
Fluticasone Propionate	Fluticasone Propionate	58	26
Montelukast Sodium	Montelukast Sodium	56	18
Spironolactone	Spironolactone	53	12
Zolpidem Tartrate	Zolpidem Tartrate	50	suppressed
Trazodone Hcl	Trazodone Hcl	48	23
Fluoxetine Hcl	Fluoxetine Hcl	46	15
Rybelsus	Semaglutide	46	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	45	14
Metformin Hcl Er	Metformin Hcl	43	16
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	41	19
Quetiapine Fumarate	Quetiapine Fumarate	41	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	38	34
Escitalopram Oxalate	Escitalopram Oxalate	37	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	13
Trulicity	Dulaglutide	37	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	36	33
Tramadol Hcl	Tramadol Hcl	36	13
Alendronate Sodium	Alendronate Sodium	35	14
Ezetimibe	Ezetimibe	34	11
Synthroid	Levothyroxine Sodium	33	suppressed
Glimepiride	Glimepiride	32	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	31	suppressed
Clopidogrel	Clopidogrel Bisulfate	29	12
Dexlansoprazole Dr	Dexlansoprazole	28	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	28	suppressed
Oxycodone Hcl	Oxycodone Hcl	28	suppressed
Paroxetine Hcl	Paroxetine Hcl	28	suppressed
Pregabalin	Pregabalin	27	suppressed
Nabumetone	Nabumetone	26	12
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	25	suppressed
Propranolol Hcl Er	Propranolol Hcl	25	suppressed
Xarelto	Rivaroxaban	25	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	24	11
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	11
Lorazepam	Lorazepam	21	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	21	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	20	suppressed
Torsemide	Torsemide	20	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	19	suppressed
Buspirone Hcl	Buspirone Hcl	19	suppressed
Enalapril Maleate	Enalapril Maleate	19	suppressed
Levetiracetam	Levetiracetam	19	suppressed
Amoxicillin	Amoxicillin	18	15
Cephalexin	Cephalexin	18	17
Clonazepam	Clonazepam	18	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	17	suppressed
Memantine Hcl	Memantine Hcl	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Allopurinol	Allopurinol	16	suppressed
Glipizide	Glipizide	16	suppressed
Lovastatin	Lovastatin	16	suppressed
Nifedipine Er	Nifedipine	16	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Azelastine Hcl	Azelastine Hcl	15	suppressed
Baclofen	Baclofen	15	suppressed
Bupropion Xl	Bupropion Hcl	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Glipizide Er	Glipizide	15	suppressed
Ibuprofen	Ibuprofen	15	suppressed
Januvia	Sitagliptin Phosphate	15	suppressed
Methylprednisolone	Methylprednisolone	15	suppressed
Minocycline Hcl	Minocycline Hcl	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	15	suppressed
Atenolol	Atenolol	14	suppressed
Azithromycin	Azithromycin	14	14
Mirtazapine	Mirtazapine	14	suppressed
Carvedilol	Carvedilol	13	suppressed
Fentanyl	Fentanyl	13	suppressed
Finasteride	Finasteride	13	suppressed
Nystatin	Nystatin	13	11
Olanzapine	Olanzapine	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Cefdinir	Cefdinir	12	12
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Sotalol	Sotalol Hcl	12	suppressed
Spiriva Respimat	Tiotropium Bromide	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	11
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Farxiga	Dapagliflozin Propanediol	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Lidocaine	Lidocaine	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Ramipril	Ramipril	11	suppressed
Sildenafil Citrate	Sildenafil Citrate	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error